All Stocks/Healthcare/HIMS

Hims & Hers Health, Inc.

HIMS
HealthcareDrug Manufacturers - Specialty & Generic Website
Price ChartPowered by TradingView
Ask about HIMSAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
13.08M$424.55MNEW
Renaissance Technologies
Jim Simons (founder)
4.82M$156.44MNEW
D.E. Shaw
David Shaw
4.68M$151.96MNEW
Point72
Steve Cohen
667K$21.67MNEW
Marshall Wace6K$204.5KNEW
About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. is a leading telehealth platform that connects consumers to licensed healthcare professionals for personalized medical care. The company operates a direct-to-consumer model, offering consultations, prescription medications, over-the-counter products, and wellness solutions across specialties including sexual health, hair care, skincare, mental health, weight loss, dermatology, and primary care. Customers engage through a secure online intake process, receive evaluations from vetted providers in all 50 U.S. states and internationally in countries like the United Kingdom, Canada, Germany, France, Spain, and Ireland, and access treatments shipped discreetly from partner pharmacies. Hims & Hers emphasizes asynchronous messaging for convenience, ongoing clinical support, educational resources, laboratory testing for biomarkers, and curated non-prescription items such as supplements, cosmetics, and devices focused on general wellness. Founded in 2017 and headquartered in San Francisco, California, the platform prioritizes clinical quality, customer privacy, and accessibility to normalize health challenges and empower informed decisions.

CEO
Mr. Andrew Dudum
Employees
2,442
Quick Facts
Exchange
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap
Key Dates

Earnings calendar coming soon. Subscribe to get notified when HIMS reports next.

Get earnings alerts →